- increased circulating creatine kinase level / IMPC
- increased circulating amylase level / IMPC
- increased kidney weight / IMPC
- cataract / IMPC
- increased lean body mass / IMPC
- increased circulating cholesterol level / IMPC
- increased circulating alkaline phosphatase level / IMPC
- decreased bone mineral content / IMPC
- increased fasting circulating glucose level / IMPC
- decreased bone mineral density / IMPC
- impaired glucose tolerance / IMPC
- increased heart weight / IMPC
- increased circulating alanine transaminase level / IMPC
- abnormal gait / IMPC
- decreased total body fat amount / IMPC
- tremors / IMPC
- increased circulating bilirubin level / IMPC
- increased circulating aspartate transaminase level / IMPC
- increased circulating iron level / IMPC
- preweaning lethality, incomplete penetrance / IMPC
- decreased circulating glucose level / IMPC
C57BL/6N-Agltm1a(EUCOMM)Wtsi/H
Status | Available to order |
EMMA ID | EM:05784 |
Citation information | RRID:IMSR_EM:05784 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | C57BL/6N-Agltm1a(EUCOMM)Wtsi/H |
Alternative name | EPD0371_2_E12 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Agltm1a(EUCOMM)Wtsi |
Gene/Transgene symbol | Agl |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | MRC, Medical Research Council |
Provider affiliation | Mary Lyon Centre at MRC Harwell |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0371_2_E12. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Animals used for archiving | heterozygous C57BL/6NTac males |
Breeding at archiving centre | Chimeras were mated to C57BL/6N Tac USA and maintained on this background thereafter. |
Disease and phenotype information
MGI allele-associated human disease models
Orphanet associated rare diseases, based on orthologous gene matching
- Glycogen storage disease due to glycogen debranching enzyme deficiency / Orphanet_366
IMPC phenotypes (gene matching)
MGI phenotypes (allele matching)
- hypoglycemia / MGI
- enlarged liver / MGI
- abnormal hepatocyte morphology / MGI
- muscle weakness / MGI
- hypoactivity / MGI
- premature death / MGI
- increased circulating alanine transaminase level / MGI
- increased circulating alkaline phosphatase level / MGI
- liver fibrosis / MGI
- increased circulating aspartate transaminase level / MGI
- decreased grip strength / MGI
- increased circulating creatine kinase level / MGI
- increased liver glycogen level / MGI
- increased skeletal muscle glycogen level / MGI
- increased cardiac muscle glycogen level / MGI
MGI phenotypes (gene matching)
- kyphosis / MGI
- hypoglycemia / MGI
- abnormal liver morphology / MGI
- enlarged liver / MGI
- abnormal hepatocyte morphology / MGI
- muscle weakness / MGI
- hypoactivity / MGI
- impaired coordination / MGI
- abnormal gait / MGI
- premature death / MGI
- increased circulating alanine transaminase level / MGI
- increased circulating alkaline phosphatase level / MGI
- liver fibrosis / MGI
- increased circulating aspartate transaminase level / MGI
- increased glycogen level / MGI
- decreased circulating glucose level / MGI
- increased pulmonary respiratory rate / MGI
- decreased grip strength / MGI
- increased circulating creatine kinase level / MGI
- increased liver glycogen level / MGI
- increased skeletal muscle glycogen level / MGI
- impaired exercise endurance / MGI
- decreased fasted circulating glucose level / MGI
- increased cardiac muscle glycogen level / MGI
- increased brain glycogen level / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).